Oxalic Acid

Oxalic Acid

SCHEMBL7148808

CN1CC2CCCC(C1)C2CC(=O)O.O=C(O)C(=O)O

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

OPRM1SLC6A4

The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 1/20 0.41
ICAM1 P05362 1/20 0.34
VCAM1 P19320 1/20 0.34
KHK P50053 2/20 0.33
ALDH1A1 P00352 2/20 0.33
KDM4E B2RXH2 2/20 0.32
SMN1; SMN2 Q16637 1/20 0.31
ACE P12821 2/20 0.30
TSHR P16473 1/20 0.30
HSD17B10 Q99714 1/20 0.30
REN P00797 1/20 0.30
GFER P55789 1/20 0.30
OPRD1 P41143 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6749057 0.96 HSD11B1 (0.44) HSD11B1ICAM1VCAM1KHKALDH1A1
SCHEMBL19000148 0.81 HSD11B1 (0.52) HSD11B1ALDH1A1TSHR
SCHEMBL6747271 0.79 ITGB3 (0.34) ALDH1A1SMN1; SMN2ACEREN
SCHEMBL3754325 0.78 HSD11B1 (0.56) HSD11B1KDM4ETSHRHSD17B10
SCHEMBL20417970 0.73 ARG1 (0.31) SMN1; SMN2
SCHEMBL19051289 0.72 HSD11B1 (0.40) HSD11B1KHKTSHR
SCHEMBL20652118 0.72 HSD11B1 (0.39) HSD11B1ICAM1VCAM1ACEHSD17B10
SCHEMBL7142983 0.72 HRH3 (0.33)
SCHEMBL7142985 0.72 HRH3 (0.33)
SCHEMBL8319934 0.71 ALDH1A1 (0.37) HSD11B1ALDH1A1KDM4ETSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6518423-B1 These compounds are useful as drugs efficacious in the prevention and treatment of these various inflammatory diseases and immunologic diseases, such as rheumatoid arthritis, atopic dermatitis, psoriasis, asthma, and EISAI CO., LTD. (JP) 2003-02-11 US disclosed
EP-0934941-A1 BENZOPIPERIDINE DERIVATIVES Eisai Co., Ltd. (JP) 1999-08-11 EP disclosed